HCA
HCAT icon

Harbor Capital Advisors’s Health Catalyst HCAT Stock Holding History

Harbor Capital Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,617
Closed -$20K – 1232
2026
Q1 		$20K Buy
+15,617
New +$29.4K ﹤0.01% 834
2025
Q1 		– Sell
-10,886
Closed -$77K – 1465
2024
Q4 		$77K Sell
10,886
-878
-7% -$6.99K ﹤0.01% 712
2024
Q3 		$96K Buy
11,764
+2,064
+21% +$14.9K ﹤0.01% 721
2024
Q2 		$62K Sell
9,700
-14,250
-59% -$91.5K ﹤0.01% 713
2024
Q1 		$180K Buy
23,950
+13,005
+119% +$119K 0.02% 625
2023
Q4 		$101K Buy
10,945
+218
+2% +$1.78K 0.02% 417
2023
Q3 		$109K Sell
10,727
-1,257
-10% -$15K 0.02% 410
2023
Q2 		$150K Buy
+11,984
New +$143K 0.03% 394

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harbor Capital Advisors's HCAT Position: Q2 2026 in Review

Harbor Capital Advisors sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 15,617 shares — an estimated $20K sold.

Harbor Capital Advisors first reported a position in HCAT in Q2 2023 and held it in 8 quarters. The position peaked at $180K in Q1 2024. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Harbor Capital Advisors reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 15,617 Health Catalyst shares in Q2 2026, an estimated $20K.
  • Harbor Capital Advisors first reported a position in Health Catalyst in Q2 2023 and held it in 8 quarters.
  • Harbor Capital Advisors's Health Catalyst position peaked at $180K in Q1 2024.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.